ライフサイエンスコーパス: lower urinary tract symptom

1 eating OAB symptoms in children and men with lower urinary tract symptom.

2 ation and progression of clinically relevant lower urinary tract symptoms.

3 gies (self-management) available to men with lower urinary tract symptoms.

4 mary aim of investigation for a patient with lower urinary tract symptoms.

5 n delivery had a protective association with lower urinary tract symptoms.

6 ary evaluation of the female presenting with lower urinary tract symptoms.

7 reatment of benign prostatic hyperplasia and lower urinary tract symptoms.

8 ing to void) were positively associated with lower urinary tract symptoms.

9 recapitulate several clinical components of lower urinary tract symptoms.

10 is one of the most common and bothersome of lower urinary tract symptoms.

11 tive as alpha1-adrenoceptor blockers in male lower urinary tract symptoms.

12 urinary tract infection was associated with lower urinary tract symptoms.

13 of bladder outlet obstruction in males with lower urinary tract symptoms.

14 nificantly associated with susceptibility to lower urinary tract symptoms.

15 perative to accurately define terminology of lower urinary tract symptoms.

16 association between toileting behaviours and lower urinary tract symptoms.

17 reatment of benign prostatic hyperplasia and lower urinary tract symptoms.

18 association between toileting behaviours and lower urinary tract symptoms.

19 trual period were negatively associated with lower urinary tract symptoms.

20 evaluated anticholinergic drugs in men with lower urinary tract symptoms.

21 ness and safety of anticholinergics for male lower urinary tract symptoms.

22 stress incontinence without increasing other lower urinary tract symptoms.

23 How such therapies for lower urinary tract symptoms affect sexual function in m

24 e and behavioural interventions for men with lower urinary tract symptoms aim to allow the patient so

25 eing essential in the assessment of men with lower urinary tract symptoms, although there are no high

26 Lower urinary tract symptoms among female nurses should

27 study aimed to investigate the prevalence of lower urinary tract symptoms among female nurses, and th

28 Medical therapy for lower urinary tract symptoms and benign prostatic hyperp

29 the issue of combination medical therapy for lower urinary tract symptoms and benign prostatic hyperp

30 From the literature, it is known that lower urinary tract symptoms and benign prostatic hyperp

31 sy has surrounded the evaluation of men with lower urinary tract symptoms and benign prostatic obstru

32 Most of the data linking lower urinary tract symptoms and erectile dysfunction su

33 ncontrolled congestive heart failure, severe lower-urinary-tract symptoms, and erythrocytosis.

34 uria, have meant a shift in the way men with lower urinary tract symptoms are assessed and managed.

35 l history is a key step in assessing whether lower urinary tract symptoms are due to BPH or to some o

36 In men, lower urinary tract symptoms are most often attributed t

37 Male lower urinary tract symptoms are often attributed to ben

38 In women, lower urinary tract symptoms are often considered to res

39 y over the last decade and now most men with lower urinary tract symptoms are treated at some point w

40 There was an improvement in lower urinary tract symptoms, assessed by International

41 Nearly all older men will experience lower urinary tract symptoms associated with benign pros

42 fruit extracts are widely used for treating lower urinary tract symptoms attributed to benign prosta

43 ta regarding the incidence and prevalence of lower urinary tract symptoms/benign prostatic hyperplasi

44 cy of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasi

45 es of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasi

46 qualitative and quantitative improvements in lower urinary tract symptoms, but also in offering a day

47 gnaling decreases BPH volume and can relieve lower urinary tract symptoms, but the mechanisms of andr

48 or treatment of storage symptoms in men with lower urinary tract symptoms, combinations of antimuscar

49 Lower urinary tract symptoms due to benign prostatic hyp

50 of diagnostic test accuracy among males with lower urinary tract symptoms due to bladder outlet obstr

51 st-effective and accurate analysis of female lower urinary tract symptoms, existing technology must b

52 aluation is the accurate characterization of lower urinary tract symptoms for the purposes of treatme

53 The main outcome was a change in a man's lower urinary tract symptom from baseline as measured by

54 A substantial proportion of men with lower urinary tract symptoms have a combination of both

55 toileting behaviours exist among women, and lower urinary tract symptoms have a high prevalence and

56 Male patients with lower urinary tract symptoms have historically been mana

57 reatment of benign prostatic hyperplasia and lower urinary tract symptoms have yet to be performed.

58 mptoms and erectile dysfunction suggest that lower urinary tract symptoms impair the overall quality

59 Combination medical therapy improves lower urinary tract symptom in men with symptomatic beni

60 We present a case report of AUV with lower urinary tract symptoms in a 6-year-old boy with co

61 tion of prostatic stents in the treatment of lower urinary tract symptoms in men secondary to benign

62 ignaling, and BSM remodeling associated with lower urinary tract symptoms in patients with BPH.

63 ore symptomatic among the cohort of men with lower urinary tract symptoms in the community.

64 ersies and developments in the evaluation of lower urinary tract symptoms in the female, and briefly

65 me guidance for the structured evaluation of lower urinary tract symptoms in the female, especially w

66 tial components of the initial evaluation of lower urinary tract symptoms in the female.

67 ed risks of benign prostatic hyperplasia and lower urinary tract symptoms include obesity, diabetes,

68 ides benefit for men with moderate to severe lower urinary tract symptoms including overactive bladde

69 blockers can be useful for treatment of male lower urinary tract symptoms, including the overactive b

70 The assessment of lower urinary tract symptoms is an essential component o

71 When further investigation of lower urinary tract symptoms is being considered, indivi

72 In both sexes, the etiology of lower urinary tract symptoms is multifactorial, and symp

73 ng study for the evaluation of patients with lower urinary tract symptoms is not suggested by America

74 Medical treatment of lower urinary tract symptoms is the mainstay of therapy

75 elationship between toileting behaviours and lower urinary tract symptoms is unclear.

76 'Lower urinary tract symptoms' is a term that describes s

77 Lower urinary tract symptoms (LUTS) are a common conditi

78 Lower urinary tract symptoms (LUTS) are a range of irrit

79 Lower urinary tract symptoms (LUTS) associated with beni

80 n prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) commonly affect olde

81 Worldwide, lower urinary tract symptoms (LUTS) due to benign prosta

82 miologic studies evaluating risk factors for lower urinary tract symptoms (LUTS) have focused on Whit

83 ies in men with benign prostatic hyperplasia/lower urinary tract symptoms (LUTS) in 2014.

84 jaculation, were investigated in relation to lower urinary tract symptoms (LUTS) in a large case-cont

85 inflammation may play a role in the cause of lower urinary tract symptoms (LUTS) in older men.

86 benign prostatic hyperplasia commonly cause lower urinary tract symptoms (LUTS) in the renal transpl

87 examined the association between obesity and lower urinary tract symptoms (LUTS) in the Third Nationa

88 d or acidic beverages as self-management for lower urinary tract symptoms (LUTS) is limited.

89 tatic hyperplasia (BPH) as the main cause of lower urinary tract symptoms (LUTS) may lead to acute ur

90 d women, there is an increasing incidence of lower urinary tract symptoms (LUTS) which are increasing

91 ncreases in benign prostatic enlargement and lower urinary tract symptoms (LUTS), and it is not clear

92 rrent evidence linking lifestyle factors and lower urinary tract symptoms (LUTS), and their relevance

93 or a role of inflammation in the etiology of lower urinary tract symptoms (LUTS), raising the possibi

94 se of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), recent epidemiologi

95 Chronic lower urinary tract symptoms (LUTS), such as urgency and

96 e varied pathophysiologic mechanisms causing lower urinary tract symptoms (LUTS).

97 ction therapy as an alternative treatment of lower urinary tract symptoms (LUTS).

98 ultifactorial problem that may include other lower urinary tract symptoms (LUTS).

99 matic benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

100 may contribute to the development of BPH and lower urinary tract symptoms (LUTS).

101 H) effect symptomology in men suffering from lower urinary tract symptoms (LUTS).

102 the cause of clinically significant BPH with lower urinary tract symptoms (LUTS).

103 is prevalent in old men and often results in lower urinary tract symptoms (LUTS).

104 pment of benign prostatic hyperplasia and/or lower urinary tract symptoms (LUTS).

105 e and benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

106 Men with overactive bladder and other lower urinary tract symptoms may not respond to monother

107 is of bladder outlet obstruction in men with lower urinary tract symptoms may reduce the need for inv

108 ut only approximately two-thirds of men with lower urinary tract symptoms meet the accepted diagnosti

109 a saw palmetto fruit extract did not reduce lower urinary tract symptoms more than placebo.

110 ly 68% of the female nurses had at least one lower urinary tract symptom, nearly 50% had incontinence

111 nic obstructive pulmonary disease, glaucoma, lower urinary tract symptoms, non-ST-segment elevation m

112 of drugs currently used for the treatment of lower urinary tract symptoms/overactive bladder syndrome

113 dergo surgery but scored 15-35 points on the lower urinary tract symptom questionnaire of the America

114 1-0.52) and urinary symptoms (Bristol Female Lower Urinary Tract Symptoms Questionnaire; P=.002; effe

115 r who scored > or = 15 points of 35 on seven lower urinary tract symptom questions modified from the

116 Alpha1-adrenergic antagonists relieve lower urinary tract symptoms related to benign prostatic

117 s the participants' toileting behaviours and lower urinary tract symptoms, respectively.

118 ltation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms scales were used to assess

119 From 1990 through 2000, lower urinary tract symptom severity was assessed by the

120 havioural programme can significantly reduce lower urinary tract symptoms severity and decrease objec

121 Men presenting with lower urinary tract symptoms should undergo comprehensiv

122 Progressive neurological disease can cause lower urinary tract symptoms similar to those seen in bl

123 c hyperplasia, sexually transmitted disease, lower urinary tract symptoms, stress, and reduced sunlig

124 escribed medical therapy in the treatment of lower urinary tract symptom suggestive of benign prostat

125 Men who have lower urinary tract symptoms that are consistent with be

126 th a diagnosis of BPH and moderate-to-severe lower urinary tract symptoms that were refractory to med

127 drawn from a general population of men with lower urinary tract symptoms, the calculations of incide

128 Among males with lower urinary tract symptoms, the likelihood ratios (LRs

129 In patients with lower urinary tract symptoms, the symptoms alone are not

130 lly well tolerated therapy for patients with lower urinary tract symptoms thought to be associated wi

131 of standard benign prostatic hyperplasia and lower urinary tract symptoms treatment algorithms is pot

132 In men with lower urinary tract symptoms treatment may need to be di

133 etiologies may exist in the individual with lower urinary tract symptoms, treatment may fail as a re

134 However, lower urinary tract symptoms were not significantly asso

135 ostate hyperplasia (BPH) is a major cause of lower urinary tract symptoms, with an increased volume o